Literature DB >> 23756206

Invasive African Salmonella Typhimurium induces bactericidal antibodies against O-antigens.

Simona Rondini1, Luisa Lanzilao, Francesca Necchi, Colette M O'Shaughnessy, Francesca Micoli, Allan Saul, Calman A MacLennan.   

Abstract

Nontyphoidal Salmonella are a major and emerging cause of fatal invasive disease in Africa, and are genetically distinct from those found elsewhere in the world. Understanding the targets of protective immunity to these African Salmonellae is key to vaccine development. We immunized mice and rabbits with heat-inactivated wild-type African invasive Salmonella Typhimurium D23580 and rough mutants lacking O-antigen. Wild-type Salmonella, unlike rough bacteria, induced a large bactericidal antibody response mainly against O-antigen. Bactericidal ability of anti-O-antigen antibodies was confirmed following purification by affinity chromatography. The current findings support the development of an O-antigen conjugate vaccine against invasive nontyphoidal Salmonellae for Africa.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Conjugate vaccine; NTS; Nontyphoidal Salmonella; O-antigen

Mesh:

Substances:

Year:  2013        PMID: 23756206     DOI: 10.1016/j.micpath.2013.05.014

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  26 in total

1.  Comparing the roles of antibodies to nontyphoidal Salmonella enterica in high- and low-income countries and implications for vaccine development.

Authors:  Calman A MacLennan; Sharon M Tennant
Journal:  Clin Vaccine Immunol       Date:  2013-07-31

2.  Effect of human immunodeficiency virus infection on plasma bactericidal activity against Salmonella enterica serovar Typhimurium.

Authors:  Estela Trebicka; Nanda Kumar N Shanmugam; Anastassia Mikhailova; Galit Alter; Bobby J Cherayil
Journal:  Clin Vaccine Immunol       Date:  2014-08-13

3.  Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.

Authors:  S Rondini; F Micoli; L Lanzilao; M Gavini; R Alfini; C Brandt; S Clare; P Mastroeni; A Saul; C A MacLennan
Journal:  Infect Immun       Date:  2014-12-29       Impact factor: 3.441

4.  Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines.

Authors:  Mary Adetinuke Boyd; Sharon M Tennant; Venant A Saague; Raphael Simon; Khitam Muhsen; Girish Ramachandran; Alan S Cross; James E Galen; Marcela F Pasetti; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2014-03-12

5.  Relationship between antibody susceptibility and lipopolysaccharide O-antigen characteristics of invasive and gastrointestinal nontyphoidal Salmonellae isolates from Kenya.

Authors:  Robert S Onsare; Francesca Micoli; Luisa Lanzilao; Renzo Alfini; Chinyere K Okoro; Anne W Muigai; Gunturu Revathi; Allan Saul; Samuel Kariuki; Calman A MacLennan; Simona Rondini
Journal:  PLoS Negl Trop Dis       Date:  2015-03-04

6.  Monoclonal Antibodies of a Diverse Isotype Induced by an O-Antigen Glycoconjugate Vaccine Mediate In Vitro and In Vivo Killing of African Invasive Nontyphoidal Salmonella.

Authors:  Yun Shan Goh; Simon Clare; Francesca Micoli; Allan Saul; Pietro Mastroeni; Calman A MacLennan
Journal:  Infect Immun       Date:  2015-07-13       Impact factor: 3.441

7.  Sequential acquisition of T cells and antibodies to nontyphoidal Salmonella in Malawian children.

Authors:  Tonney S Nyirenda; James J Gilchrist; Nicholas A Feasey; Sarah J Glennie; Naor Bar-Zeev; Melita A Gordon; Calman A MacLennan; Wilson L Mandala; Robert S Heyderman
Journal:  J Infect Dis       Date:  2014-01-16       Impact factor: 5.226

8.  Long-Term Anti-Bacterial Immunity against Systemic Infection by Salmonella enterica Serovar Typhimurium Elicited by a GMMA-Based Vaccine.

Authors:  Fabio Fiorino; Elena Pettini; Oliver Koeberling; Annalisa Ciabattini; Gianni Pozzi; Laura B Martin; Donata Medaglini
Journal:  Vaccines (Basel)       Date:  2021-05-12

9.  Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease.

Authors:  Luisa Lanzilao; Giuseppe Stefanetti; Allan Saul; Calman A MacLennan; Francesca Micoli; Simona Rondini
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

Review 10.  Vaccines against invasive Salmonella disease: current status and future directions.

Authors:  Calman A MacLennan; Laura B Martin; Francesca Micoli
Journal:  Hum Vaccin Immunother       Date:  2014-05-07       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.